Cambridge Vision Technology Analysis

First early warning system for Alzheimer's via optician visits

Screen for Alzheimer's during routine eye exams; Detect early signs of neurodegenerative diseases in optician visits; Enable early intervention for patients with retinal disease markers; Identify cardiovascular risk factors linked to Alzheimer's; Provide clinicians with actionable biomarkers for patient monitoring

Scientifically validated diagnostic tests; Focus on early detection through optician visits; Partnerships with optician networks; Validated for ophthalmic, cardiovascular, and neurodegenerative diseases; Available in US, UK, and Switzerland